Anti-VEGFR2 (Ab-1214) Antibody

This polyclonal reagent from Antibodies.com targets vascular endothelial growth factor receptor 2 (VEGFR2), a type I transmembrane receptor tyrosine kinase (also called KDR in humans and Flk-1 in mouse) that drives angiogenic signaling in vascular endothelial cells. Raised in rabbit against a peptide sequence surrounding residue 1214 of VEGFR2, a region that encompasses a documented autophosphorylation site involved in PLCγ recruitment, the antibody is supplied as 100 µl of unconjugated antiserum intended for research use only.

The reagent has been validated across Western blot, immunohistochemistry, and immunofluorescence workflows and cross-reacts with VEGFR2 from human, mouse, and rat samples, supporting studies of tumor angiogenesis, vascular development, wound healing, and endothelial cell biology. For best stability, aliquot the vial upon arrival and store at -20 °C; avoid repeated freeze-thaw cycles and protect from light to preserve binding activity. Each shipment is supplied as a single-use research-grade vial and is not cleared for diagnostic or therapeutic use.